HK2 and ovarian cancer: We found that after infection with shPGC1α and the simultaneous addition of cisplatin, the mitochondrial localization of HK2 and the binding of HK2 and VDAC1 in ovarian cancer drug-resistant cells decreased and apoptosis increased.